These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23879042)

  • 1. [Experience in noninvasively quantifying hydrogen magnetic resonance imaging spectroscopic hepatic fat concentrations in patients with fatty hepatosis before and after treatment with Eslidin].
    Shariia MA; Shriaev GA; Titov VN; Ivanova KV
    Vestn Rentgenol Radiol; 2013; (2):50-4. PubMed ID: 23879042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
    van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
    Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty infiltration of the liver: evaluation by proton spectroscopic imaging.
    Heiken JP; Lee JK; Dixon WT
    Radiology; 1985 Dec; 157(3):707-10. PubMed ID: 2997837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique.
    Pineda N; Sharma P; Xu Q; Hu X; Vos M; Martin DR
    Radiology; 2009 Aug; 252(2):568-76. PubMed ID: 19546430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR spectroscopic studies of lipid extracts from human fatty liver.
    Pollesello P; Masutti F; Crocè LS; Toffanin R; Eriksson O; Paoletti S; Höckerstedt K; Tiribelli C
    Biochem Biophys Res Commun; 1993 May; 192(3):1217-22. PubMed ID: 8507193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy.
    van Werven JR; Schreuder TC; Nederveen AJ; Lavini C; Jansen PL; Stoker J
    Eur J Radiol; 2010 Aug; 75(2):e102-7. PubMed ID: 20116951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduced insulin effect in subclinical fatty liver].
    Thamer C; Machann J; Haap M; Bachmann O; Wietek B; Dahl D; Tschritter O; Fritsche A; Jacob S; Schick F; Stumvoll M; Häring H
    Dtsch Med Wochenschr; 2004 Apr; 129(16):872-5. PubMed ID: 15083407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of intrahepatic triglyceride stores by 1H magnetic resonance spectroscopy: study with rat models and in patients].
    Liu M; Gao X; Rao SX; Wu L; Zeng MS
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):531-3. PubMed ID: 18649768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders.
    Johnson NA; Walton DW; Sachinwalla T; Thompson CH; Smith K; Ruell PA; Stannard SR; George J
    Hepatology; 2008 May; 47(5):1513-23. PubMed ID: 18393289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].
    Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ
    Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry.
    Roldan-Valadez E; Favila R; Martínez-López M; Uribe M; Ríos C; Méndez-Sánchez N
    J Hepatol; 2010 Oct; 53(4):732-7. PubMed ID: 20594607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis.
    Longo R; Pollesello P; Ricci C; Masutti F; Kvam BJ; Bercich L; Crocè LS; Grigolato P; Paoletti S; de Bernard B
    J Magn Reson Imaging; 1995; 5(3):281-5. PubMed ID: 7633104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of total lipid extracts from human liver by 13C and 1H nuclear magnetic resonance spectroscopy.
    Pollesello P; Eriksson O; Hockerstedt K
    Anal Biochem; 1996 Apr; 236(1):41-8. PubMed ID: 8619494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.
    Kotronen A; Peltonen M; Hakkarainen A; Sevastianova K; Bergholm R; Johansson LM; Lundbom N; Rissanen A; Ridderstråle M; Groop L; Orho-Melander M; Yki-Järvinen H
    Gastroenterology; 2009 Sep; 137(3):865-72. PubMed ID: 19524579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy.
    Krssák M; Hofer H; Wrba F; Meyerspeer M; Brehm A; Lohninger A; Steindl-Munda P; Moser E; Ferenci P; Roden M
    Eur J Radiol; 2010 Jun; 74(3):e60-6. PubMed ID: 19406596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy.
    Marsman HA; van Werven JR; Nederveen AJ; Ten Kate FJ; Heger M; Stoker J; van Gulik TM
    J Magn Reson Imaging; 2010 Jul; 32(1):148-54. PubMed ID: 20578022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The functional condition of the hepato-biliary system in fatty hepatosis with concomitant diabetes mellitus].
    Suchkova EV
    Eksp Klin Gastroenterol; 2009; (8):26-9. PubMed ID: 20469675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
    Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
    Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.